Home LiteratureArticle Details
PMID: 8762112 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Anti-inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy.

British journal of pharmacology ·Vol. 118 ·No. 3 ·1996-06-00 ·Pages 811-9

Saleh TS, Calixto JB, Medeiros YS

Abstract

1. The aim of this study was to examine the effect of theophylline, cromolyn and salbutamol, three well-known anti-asthmatic drugs, on the early (4 h) and late (48 h) phases of cell migration and fluid leakage induced by carrageenin in the pleural cavity of mice. 2. In the first set of experiments, animals were pretreated (30 min) with different doses of theophylline (0.5-50 mg kg-1, i.p.), cromolyn (0.02-0.2 mg per pleural cavity) or salbutamol (0.05-50 mg kg-1, i.p.); the total and differential cell content, and also the exudate were analysed 4 h after carrageenin (1%) administration. Afterwards, in order to evaluate the time course effects of these drugs on both phases of the inflammatory reaction, one dose employed in the above protocol was chosen, to pretreat (0.5-24 h) different groups of animals. The studied parameters were evaluated 4 and 48 h after pleurisy induction. 3. Acute administration of theophylline (1-50 mg kg-1, i.p.) cromolyn (0.02-0.2 mg per pleural cavity) and salbutamol (0.5-50 mg kg-1, i.p.), 30 min prior to carrageenin, caused significant inhibition of total cell and fluid leakage in the pleural cavity at 4 h (P < 0.01). All drugs exerted a long-lasting inhibitory effect on both exudation and cell migration (P < 0.01) when administered 0.5-8 h before pleurisy induction. However, the temporal profile of the inhibitory effect induced by these drugs on the first phase of the inflammatory reaction was clearly different. Thus, the inhibitory effect induced by theophylline and cromolyn on exudation was significantly longer (up to 24 h) in comparison to their effects on cell migration (only up to 8 h). In contrast, although salbutamol when administered 30 min before pleurisy induction abolished fluid leakage (P < 0.01), this effect was not sustained in the groups pretreated for 4-8 h. In these latter groups, a significant but much smaller reduction of exudation was observed (P < 0.01), whereas the magnitude of cell migration inhibition did not vary. 4. The second phase (48 h) of the inflammatory reaction induced by carrageenin (1%) was significantly inhibited by cromolyn (0.02 mg per pleural cavity) when this drug was administered 0.5-24 h before pleurisy induction (P < 0.01). Similar results were observed when theophylline (50 mg kg-1, i.p.) was administered 0.5-4 h before the injection of the phlogistic agent (P < 0.01). Treatment of the animals with salbutamol (5 mg kg-1, i.p.), 0.5-24 h before pleurisy induction, did not inhibit either cell migration or fluid leakage. In this condition, a significant increase of these parameters was observed in the group pretreated with salbutamol 8-24 h before pleurisy induction (P < 0.01). 5. These results indicate that theophylline and cromolyn were able to inhibit the early (4 h) and late (48 h) phases of the inflammatory reaction induced by carrageenin in a murine model of pleurisy. Salbutamol was effective only against the early phase. The inhibitory effects of theophylline, cromolyn and salbutamol on the early phase of this inflammatory reaction were long-lasting, although a distinct profile of inhibition was observed among them. These findings confirm and extend previous results described in other models of asthma and support both clinical and experimental evidence suggesting that these anti-asthmatic agents exhibit marked anti-inflammatory properties.

MeSH Terms
Albuterol/pharmacology Animals Cromolyn Sodium/pharmacology Disease Models, Animal Dose-Response Relationship, Drug Female Male Mice Mice, Inbred Strains Pleurisy/drug therapy Theophylline/pharmacology Time Factors
Chemicals
Theophylline Cromolyn Sodium Albuterol
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Saleh T S
Department of Pharmacology, Centre of Biological Sciences, Universidade Federal de Santa Catarina, Brazil.
Calixto J B
Medeiros Y S
References (31)
31 references, click to expand
  1. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance.
    J Allergy Clin Immunol. 1981 Nov;68(5):347-55 PMID: 7028842
  2. Acute versus chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs.
    Br J Pharmacol. 1995 Jan;114(1):93-8 PMID: 7536098
  3. Late asthmatic responses.
    Am Rev Respir Dis. 1987 Sep;136(3):740-51 PMID: 3115156
  4. New aspects of the therapeutic potential of theophylline in asthma.
    J Allergy Clin Immunol. 1989 Feb;83(2 Pt 2):548-53 PMID: 2645351
  5. Cellular events in the bronchi in mild asthma and after bronchial provocation.
    Am Rev Respir Dis. 1989 Mar;139(3):806-17 PMID: 2923380
  6. Effect of theophylline and adenosine on eosinophil function.
    Am Rev Respir Dis. 1989 Aug;140(2):327-33 PMID: 2548425
  7. A new approach to the treatment of asthma.
    N Engl J Med. 1989 Nov 30;321(22):1517-27 PMID: 2572966
  8. Neurogenic inflammation, vascular permeability, and mast cells. II. Additional evidence indicating that mast cells are not involved in neurogenic inflammation.
    J Immunol. 1990 Aug 15;145(4):1214-21 PMID: 1696295
  9. The antiinflammatory effects of adenosine receptor agonists on the carrageenan-induced pleural inflammatory response in rats.
    J Immunol. 1990 Sep 15;145(6):1874-9 PMID: 2167912
  10. One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by beta 2-agonists.
    Lancet. 1991 Mar 23;337(8743):717-20 PMID: 1706045
  11. Theophylline inhibits early and late asthmatic reactions induced by allergens in asthmatic subjects.
    Ann Allergy. 1991 Mar;66(3):245-51 PMID: 2006773
  12. Pharmacologic control of plasma exudation into tracheobronchial airways.
    Am Rev Respir Dis. 1991 May;143(5 Pt 1):1008-14 PMID: 1902634
  13. Pharmacological modulation of a model of bronchial inflammation after aerosol-induced active anaphylactic shock in conscious guinea pigs.
    Int J Immunopharmacol. 1991;13(4):349-56 PMID: 1904844
  14. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.
    Thorax. 1991 Jul;46(7):512-23 PMID: 1877039
  15. The human skin mast cell: a comparison with the human lung cell and a novel mast cell type, the uterine mast cell.
    Agents Actions. 1991 May;33(1-2):16-9 PMID: 1716825
  16. Mechanistic aspects of cromolyn sodium action on the alveolar macrophage: inhibition of stimulation by soluble agonists.
    Agents Actions. 1991 Jul;33(3-4):318-25 PMID: 1659157
  17. Salbutamol plus beclomethasone dipropionate, but not salbutamol alone, completely prevent early and late asthmatic responses to allergen.
    Respir Med. 1991 Sep;85(5):401-6 PMID: 1759005
  18. Asthma, inflammation, eosinophils and bronchial hyperresponsiveness.
    Clin Exp Allergy. 1992 Feb;22(2):187-97 PMID: 1571812
  19. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells.
    Int Arch Allergy Immunol. 1992;97(3):216-25 PMID: 1375203
  20. Endothelin-1 inhibits PAF-induced paw oedema and pleurisy in the mouse.
    Br J Pharmacol. 1992 Jul;106(3):579-82 PMID: 1504742
  21. Development of an animal model of late asthmatic response in guinea pigs and effects of anti-asthmatic drugs.
    Prostaglandins. 1992 Jun;43(6):507-21 PMID: 1410517
  22. Leukotriene B4 level in stimulated blood neutrophils and alveolar macrophages from healthy and asthmatic subjects. Effect of beta-2 agonist therapy.
    Eur J Clin Invest. 1992 Nov;22(11):732-9 PMID: 1335872
  23. Approaches to asthma management. Realities and recommendations.
    Arch Intern Med. 1993 Apr 12;153(7):805-12 PMID: 8466374
  24. Nedocromil sodium blocks the early and late phases of allergen challenge in a guinea pig model of asthma.
    J Allergy Clin Immunol. 1993 Jul;92(1 Pt 2):177-82 PMID: 8393024
  25. Immunohistology in bronchial asthma.
    Respir Med. 1993 Aug;87 Suppl B:13-21 PMID: 8234961
  26. Theophylline target concentration in severe airways obstruction - 10 or 20 mg/L? A randomised concentration-controlled trial.
    Clin Pharmacokinet. 1993 Dec;25(6):495-505 PMID: 8119049
  27. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma.
    Lancet. 1994 Apr 23;343(8904):1006-8 PMID: 7909049
  28. Theophylline suppresses the release of tumour necrosis factor-alpha by blood monocytes and alveolar macrophages.
    Eur Respir J. 1994 Feb;7(2):223-8 PMID: 8162974
  29. K+ channel openers and suppression of airway hyperreactivity.
    Trends Pharmacol Sci. 1994 Dec;15(12):463-8 PMID: 7886819
  30. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor.
    Br J Pharmacol. 1994 Dec;113(4):1423-31 PMID: 7889300
  31. Dextran and carrageenan evoke different inflammatory responses in rat with respect to composition of infiltrates and effect of indomethacin.
    J Pharmacol Exp Ther. 1982 Apr;221(1):261-7 PMID: 6174730
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
1996-06-00
Pages
811-9
Language
English
Region
England
NLM ID
7502536
PMCID
PMC1909745
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]